PTD unknown

Selling Domantis to Glaxo looks like a great move. First they...

  1. 5,996 Posts.
    lightbulb Created with Sketch. 162
    Selling Domantis to Glaxo looks like a great move. First they get the huge cash injection. Over a dollar per share in a 1.30 company. The company they sold uses PTDs technology. Glaxo has the muscle to get it to market faster and expand the label, at which time they will be paying royalties to PTD. Cant see a down side there. What are they going to do with all that money? I see some long suffering holders selling into the rise, big mistake IMHO.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.